drugset / Trial / NCT04356300

Exosome of Mesenchymal Stem Cells for Multiple Organ Dysfuntion Syndrome After Surgical Repaire of Acute Type A Aortic Dissection

NCT04356300 ↗

Not yet recruiting 60 enrolled Fujian Medical University
RandomizedParallel-groupSingle-blindTreatment

Summary

Multiple organ dysfunction syndrome (MODS) after surgical repaired for acute type A aortic dissection (ATAAD) is a life-threatening condition. In this study, patients who undergoing surgical repaired of ATAAD immediately or presenting sever MODS after surgical repaired of acute type A aortic dissection will be treated with umbilical cord-derived mesenchymal stem cell.

Timeline

Start
2020-09-01
Primary completion
2021-09-01
Completion
2030-09-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Exosome of MSC Unknown 150 mg Intravenous
Subject Exosome of MSC Unknown 180 mg Intravenous